Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests a new way to categorize skin and mind disorders into two main groups to reduce confusion.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Researchers found that dissecting folliculitis of the scalp is linked to obesity, severity increases with duration and number of nodules, and early treatment is important to prevent scarring.

A woman's scalp condition improved with specific ointment after a hair piece caused skin issues.

The document explains the causes, types, diagnosis, and treatments of hair loss, and its psychological impact, especially on women.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

The study suggests a possible increase in androgen receptors in patients with frontal fibrosing alopecia, but more research is needed.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Hair loss from conditions like LPP and FFA can potentially be reversed with the right treatment.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Microneedles could be a better and easier way to regrow hair.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Accurate diagnosis and aggressive treatment are crucial to prevent permanent hair loss in cicatricial alopecia.